Literature DB >> 6457899

Brain levels of neuron-specific and nonneuronal enolase in Huntington's disease.

P J Marangos, S M Paul.   

Abstract

Levels of the cell-specific brain isoenzymes of enolase were determined in basal ganglia and cerebral cortical tissue of Huntington's disease and age- and sex-matched control brain. Neuron-specific enolase (NSE) levels are decreased an average of 45% in basal ganglia from patients with Huntington's disease whereas the glial-specific form of enolase, nonneuronal enolase (NNE), is not significantly altered. In contrast, levels of NSE in cerebral cortical tissue from Huntington's disease patients remains unchanged in comparison with controls whereas NNE levels are significantly increased. NNE and NSE levels appear to be specific biochemical indicators of glial and neuronal cell number and viability. Levels of these cell-specific isoenzymes may therefore prove useful in quantitating neuropathological changes in various neurological disorders.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6457899     DOI: 10.1111/j.1471-4159.1981.tb04687.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  High neuron-specific enolase level of cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease.

Authors:  Y Wakayama; S Shibuya; J Kawase; F Sagawa; Y Hashizume
Journal:  Klin Wochenschr       Date:  1987-08-17

2.  Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system.

Authors:  J A Royds; G A Davies-Jones; N A Lewtas; W R Timperley; C B Taylor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-11       Impact factor: 10.154

3.  Neuroprotective effect of Moringa oleifera leaf extract on aluminium-induced temporal cortical degeneration.

Authors:  Moses B Ekong; Mfon M Ekpo; Edet O Akpanyung; Dennis U Nwaokonko
Journal:  Metab Brain Dis       Date:  2017-04-11       Impact factor: 3.584

4.  Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease.

Authors:  K Kato; N Kurobe; F Suzuki; R Morishita; T Asano; T Sato; T Inagaki
Journal:  J Mol Neurosci       Date:  1991       Impact factor: 3.444

5.  Bioenergetic deficits in Huntington's disease iPSC-derived neural cells and rescue with glycolytic metabolites.

Authors: 
Journal:  Hum Mol Genet       Date:  2020-07-21       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.